0      0


3110 - Empagliflozin on the Risk of Retinopathy in Patients with Type 2 Diabetes—Results from the EMPRISE Study


‐ Jun 25, 2023 2:15pm


Speaker(s):

You must be logged in and own this session in order to post comments.